Gilead to present HIV and antiviral data at IDWeek 2026
Gilead Sciences (Nasdaq: GILD) will present 28 abstracts, including two oral presentations, at IDWeek 2026, scheduled for October 21-24 in ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

